Published in Obesity and Diabetes Week, August 16th, 2004
Under the agreement, Genomas will use the Illumina BeadStation 500GX for the discovery of diagnostic markers to be used in the development of PhysioTypes. PhysioTypes are predictors incorporating haplotypes from various genes, baseline physiological and clinical information, and demographic data. Genomas will develop PhysioTypes for the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.